|Bid||5.7300 x 800|
|Ask||5.7500 x 1500|
|Day's Range||5.6645 - 5.8050|
|52 Week Range||3.1100 - 9.9300|
|PE Ratio (TTM)||-2.35|
|Earnings Date||Nov 1, 2017 - Nov 6, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||15.00|
WATERTOWN, Mass., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- ...
WATERTOWN, Mass., Aug. 17, 2017-- Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant infections, today ...
Tetraphase Pharmaceuticals (TTPH) needs Investors to pay close attention to the stock based on moves in the options market lately.